Association between the rate of clinical events and the crude and adjusted RRs in the study population according to metformin adherence levels
| Clinical events . | Crude RR (95% CI) . | Adjusted RR*† (95% CI) . | ||
|---|---|---|---|---|
| MPR ≥ 40% to < 80% . | MPR ≥ 80% . | MPR ≥ 40% to < 80% . | MPR ≥ 80% . | |
| All-cause inpatient encounters | 0.58 (0.27-1.22) | 0.33 (0.07-1.49) | 0.62 (0.29-1.31) | 0.38 (0.09-1.71) |
| Inpatient encounters with SCD codes | 0.64 (0.23-1.83) | 0.41 (0.05-3.34) | 0.53 (0.17-1.69) | 0.28 (0.03-2.84) |
| All-cause ED encounters | 0.94 (0.53-1.67) | 0.88 (0.28-2.79) | 0.68 (0.40-1.13) | 0.46 (0.16-1.28) |
| ED encounters with SCD codes | 0.58 (0.19-1.74) | 0.34 (0.04-3.04) | 0.74 (0.24-2.30) | 0.55 (0.06-5.31) |
| Clinical events . | Crude RR (95% CI) . | Adjusted RR*† (95% CI) . | ||
|---|---|---|---|---|
| MPR ≥ 40% to < 80% . | MPR ≥ 80% . | MPR ≥ 40% to < 80% . | MPR ≥ 80% . | |
| All-cause inpatient encounters | 0.58 (0.27-1.22) | 0.33 (0.07-1.49) | 0.62 (0.29-1.31) | 0.38 (0.09-1.71) |
| Inpatient encounters with SCD codes | 0.64 (0.23-1.83) | 0.41 (0.05-3.34) | 0.53 (0.17-1.69) | 0.28 (0.03-2.84) |
| All-cause ED encounters | 0.94 (0.53-1.67) | 0.88 (0.28-2.79) | 0.68 (0.40-1.13) | 0.46 (0.16-1.28) |
| ED encounters with SCD codes | 0.58 (0.19-1.74) | 0.34 (0.04-3.04) | 0.74 (0.24-2.30) | 0.55 (0.06-5.31) |